{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:25:01Z","timestamp":1791840301523,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T00:00:00Z","timestamp":1407110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1038\/aps.2014.57","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T05:09:38Z","timestamp":1407128978000},"page":"1111-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Alzheimer's disease progression model based on integrated biomarkers and clinical measures"],"prefix":"10.1038","volume":"35","author":[{"name":"Alzheimer's Disease Neuroimaging Initiative","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,4]]},"reference":[{"key":"BFaps201457_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR . Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 2009; 68: 1\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFaps201457_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennet DAD, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer Dement 2011; 7: 280\u201392.","journal-title":"Alzheimer Dement"},{"key":"BFaps201457_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1212\/WNL.46.3.707","volume":"46","author":"JC Morris","year":"1996","unstructured":"Morris JC, Storandt M, McKeel DWJ, Rubin EH, Price JL, Grant EA, et al. Cerebral amyloid deposition and diffuse plaques in \u201cnormal\u201d aging: evidence for pre-symptomatic and very mild Alzheimer's disease. Neurology 1996; 46: 707\u201319.","journal-title":"Neurology"},{"key":"BFaps201457_CR4","doi-asserted-by":"publisher","first-page":"11466","DOI":"10.1073\/pnas.89.23.11466","volume":"89","author":"NH Holford","year":"1992","unstructured":"Holford NH, Peace KE . Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine. Proc Natl Acad Sci U S A 1992; 89: 11466\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201457_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0091270011405497","volume":"52","author":"MN Samtani","year":"2011","unstructured":"Samtani MN, Farnum M, Lobanov V, Yang E, Raghavan N, Dibernardo A, et al. An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative. J Clin Pharmacol 2011; 52: 629\u201344.","journal-title":"J Clin Pharmacol"},{"key":"BFaps201457_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jalz.2010.12.012","volume":"8","author":"R Gomeni","year":"2012","unstructured":"Gomeni R, Simeoni M, Zvartau-Hind M, Irizarry MC, Austin D, Gold M . Modeling Alzheimer's disease progression using the disease system analysis approach. Alzheimers Dement 2012; 8: 39\u201350.","journal-title":"Alzheimers Dement"},{"key":"BFaps201457_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/clpt.2012.53","volume":"92","author":"DR Mould","year":"2012","unstructured":"Mould DR . Models for disease progression: new approaches and uses. Clin Pharmacol Therapeut 2012; 92: 125\u201331.","journal-title":"Clin Pharmacol Therapeut"},{"key":"BFaps201457_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9: 119\u201328.","journal-title":"Lancet Neurol"},{"key":"BFaps201457_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-2012-111367","volume":"30","author":"A Mouiha","year":"2012","unstructured":"Mouiha A, Duchesne S . Toward a dynamic biomarker model in Alzheimer's disease. J Alzheimers Dis 2012; 30: 91\u2013100.","journal-title":"J Alzheimers Dis"},{"key":"BFaps201457_CR10","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","volume":"60","author":"CM Clark","year":"2003","unstructured":"Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, et al. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 2003; 60: 1696\u2013702.","journal-title":"Arch Neurol"},{"key":"BFaps201457_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrd2176","volume":"6","author":"LM Shaw","year":"2007","unstructured":"Shaw LM, Korecka M, Clark CM, Lee VM, Trojanowski JQ . Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov 2007; 6: 295\u2013303.","journal-title":"Nat Rev Drug Discov"},{"key":"BFaps201457_CR12","first-page":"183","volume":"23","author":"SJ Liu","year":"2002","unstructured":"Liu SJ, Wang JZ . Alzheimer-like tau phosphorylation induced by wortmannin in vivo and its attenuation by melatonin. Acta Pharmacol Sin 2002; 23: 183\u20137.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201457_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/aps.2012.189","volume":"34","author":"WE Hochfeld","year":"2013","unstructured":"Hochfeld WE, Lee S, Rubinsztein DC . Therapeutic induction of autophagy to modulate neurodegenerative disease progression. Acta Pharmacol Sin 2013; 34: 600\u20134.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201457_CR14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","volume":"122","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW . Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984; 122: 1131\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFaps201457_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353\u20136.","journal-title":"Science"},{"key":"BFaps201457_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1745-7254.2006.00260.x","volume":"27","author":"J Wang","year":"2006","unstructured":"Wang J, Wang Z . Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol Sin 2006; 27: 41\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201457_CR17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s004010050645","volume":"93","author":"C Duyckaerts","year":"1997","unstructured":"Duyckaerts C, Uchihara T, Seilhean D, He Y, Hauw JJ . Dissociation of Alzheimer type pathology in a disconnected piece of cortex. Acta Neuropathol 1997; 93: 501\u20137.","journal-title":"Acta Neuropathol"},{"key":"BFaps201457_CR18","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 2006; 59: 512\u20139.","journal-title":"Ann Neurol"},{"key":"BFaps201457_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","volume":"64","author":"AM Fagan","year":"2007","unstructured":"Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM . Cerebrospinal fluid tau\/beta-amyloid42 ratio as a prediction of cognitive decline in non-demented older adults. Arch Neurol 2007; 64: 343\u20139.","journal-title":"Arch Neurol"},{"key":"BFaps201457_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","volume":"45","author":"JL Price","year":"1999","unstructured":"Price JL, Morris JC . Tangles and plaques in non-demented aging and \u201cpreclinical\u201d Alzheimer's disease. Ann Neurol 1999; 45: 358\u201368.","journal-title":"Ann Neurol"},{"key":"BFaps201457_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/aps.2012.188","volume":"34","author":"L He","year":"2013","unstructured":"He L, Lu J, Yue Z . Autophagy in ageing and ageing-associated diseases. Acta Pharmacol Sin 2013; 34: 605\u201311.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201457_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/1531-8249(200001)47:1<36::AID-ANA8>3.0.CO;2-L","volume":"47","author":"CJ Mummery","year":"2000","unstructured":"Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RSJ, Hodges JR . A voxel-based morphometry study of semantic dementia: Relationship between temporal lobe atrophy and semantic memory. Ann Neurol 2000; 47: 36\u201345.","journal-title":"Ann Neurol"},{"key":"BFaps201457_CR23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/sj.bjp.0705688","volume":"141","author":"S Han Y","year":"2004","unstructured":"Han Y S, Zheng WH, Bastianetto S, Chabot JG, Quirion R . Neuroprotective effects of resveratrol against \u03b2-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 2004; 141: 997\u20131005.","journal-title":"Br J Pharmacol"},{"key":"BFaps201457_CR24","first-page":"551","volume":"47","author":"XF Rong","year":"2012","unstructured":"Rong XF, Wang XL . An overview of biomarkers in Alzheimer's disease. Yao Xue Xue Bao 2012; 47: 551\u20137.","journal-title":"Yao Xue Xue Bao"},{"key":"BFaps201457_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/archneur.63.5.693","volume":"63","author":"LG Apostolova","year":"2006","unstructured":"Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 2006; 63: 693\u20139.","journal-title":"Arch Neurol"},{"key":"BFaps201457_CR26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3233\/JAD-2010-091198","volume":"20","author":"MI Kester","year":"2010","unstructured":"Kester MI, van der Flier WM, Mandic G, Blankenstein MA, Scheltens P, Muller M . Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer's disease. J Alzheimers Dis 2010; 20: 1083\u201390.","journal-title":"J Alzheimers Dis"},{"key":"BFaps201457_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.neurobiolaging.2010.04.024","volume":"31","author":"A Caroli","year":"2010","unstructured":"Caroli A, Frisoni GB . The Alzheimer's disease neuroimaging initiative. The dynamics of Alzheimer's disease biomarkers in the Alzheimer's disease neuroimaging initiative cohort. Neurobiol Aging 2010; 31: 1263\u201374.","journal-title":"Neurobiol Aging"},{"key":"BFaps201457_CR28","doi-asserted-by":"publisher","first-page":"e38639","DOI":"10.1371\/journal.pone.0038639","volume":"7","author":"S Palmqvist","year":"2012","unstructured":"Palmqvist S, Hertze J, Minthon L, Wattmo C, Zetterberg H, Blennow K, et al. Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study. PLoS One 2012; 7: e38639.","journal-title":"PLoS One"},{"key":"BFaps201457_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.neurobiolaging.2010.10.019","volume":"33","author":"M Ewers","year":"2012","unstructured":"Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR Jr, et al. Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging 2012; 33: 1203\u201314.","journal-title":"Neurobiol Aging"},{"key":"BFaps201457_CR30","doi-asserted-by":"publisher","first-page":"e21896","DOI":"10.1371\/journal.pone.0021896","volume":"6","author":"Y Cui","year":"2011","unstructured":"Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, et al. Identification of Conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One 2011; 6: e21896.","journal-title":"PLoS One"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201457","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:31:46Z","timestamp":1684398706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,4]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["BFaps201457"],"URL":"https:\/\/doi.org\/10.1038\/aps.2014.57","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,4]]},"assertion":[{"value":"21 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}